Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.K. Regulator’s Echinacea Action Sends Chills Through U.S. Industry

This article was originally published in The Tan Sheet

Executive Summary

While the risk of an allergic reaction to Echinacea in children under 12 is minimal, the U.K. medicines regulator sends a message to consumers that the age group should not take the supplement, and will require manufacturers to include warning labels.

You may also be interested in...



Durbin Bill Would Narrow Definition Of Dietary Supplement

Legislation Sen. Dick Durbin offers to stop firms from allegedly side-stepping food safety standards by labeling products as dietary supplements could have a "devastating impact on the industry," stakeholders say.

Wellness, Not Treatment Behind Most Children’s Supplement Use – NHIS Data

A National Institutes of Health survey shows children more often use dietary supplements to promote wellness than for therapeutic reasons

People In Brief

Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105932

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel